ORCID as entered in ROS

Select Publications
2020, 'Phenotypic variability in ALS-FTD and effect on survival', Neurology, 94, pp. E2005 - E2013, http://dx.doi.org/10.1212/WNL.0000000000009398
,2020, 'Cortical hyperexcitability evolves with disease progression in ALS', Annals of Clinical and Translational Neurology, 7, pp. 733 - 741, http://dx.doi.org/10.1002/acn3.51039
,2020, 'Interneuronal networks mediate cortical inhibition and facilitation', Clinical Neurophysiology, 131, pp. 1000 - 1010, http://dx.doi.org/10.1016/j.clinph.2020.02.012
,2020, 'Queen Square: a history of the National Hospital and its Institute of Neurology', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 91, pp. 560 - 561, http://dx.doi.org/10.1136/jnnp-2020-322776
,2020, 'ALS is a multistep process in South Korean, Japanese, and Australian patients', Neurology, 94, pp. E1657 - E1663, http://dx.doi.org/10.1212/WNL.0000000000009015
,2020, 'Effects of Mexiletine on Cortical and Peripheral Nerve Hyperexcitability in Sporadic ALS (2531)', Neurology, 94, http://dx.doi.org/10.1212/wnl.94.15_supplement.2531
,2020, 'Changes in long term peripheral nerve biophysical properties in childhood cancer survivors following neurotoxic chemotherapy', Clinical Neurophysiology, 131, pp. 783 - 790, http://dx.doi.org/10.1016/j.clinph.2019.12.411
,2020, 'Early focality and spread of cortical dysfunction in amyotrophic lateral sclerosis: A regional study across the motor cortices', Clinical Neurophysiology, 131, pp. 958 - 966, http://dx.doi.org/10.1016/j.clinph.2019.11.057
,2020, 'Primary lateral sclerosis: Consensus diagnostic criteria', Journal of Neurology Neurosurgery and Psychiatry, 91, pp. 373 - 377, http://dx.doi.org/10.1136/jnnp-2019-322541
,2020, 'Respiratory function and cognitive profile in amyotrophic lateral sclerosis', European Journal of Neurology, 27, pp. 685 - 691, http://dx.doi.org/10.1111/ene.14130
,2020, 'Health, wellbeing and lived experiences of adults with SMA: A scoping systematic review', Orphanet Journal of Rare Diseases, 15, pp. 70, http://dx.doi.org/10.1186/s13023-020-1339-3
,2020, 'The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis', Expert Review of Neurotherapeutics, 20, pp. 281 - 293, http://dx.doi.org/10.1080/14737175.2020.1727740
,2020, 'Expanding the availability of medications for amyotrophic lateral sclerosis in Australia', Medical Journal of Australia, 212, pp. 189 - 189.e1, http://dx.doi.org/10.5694/mja2.50482
,2020, 'Occasional essay: Upper motor neuron syndrome in amyotrophic lateral sclerosis', Journal of Neurology Neurosurgery and Psychiatry, 91, pp. 227 - 234, http://dx.doi.org/10.1136/jnnp-2019-321938
,2020, 'Characterising a human endogenous retrovirus(HERV)-derived tumour-associated antigen: enriched RNA-Seq analysis of HERV-K(HML-2) in mantle cell lymphoma cell lines', MOBILE DNA, 11, http://dx.doi.org/10.1186/s13100-020-0204-1
,2020, 'Multifocal motor neuropathy: controversies and priorities', Journal of Neurology Neurosurgery and Psychiatry, 91, pp. 140 - 148, http://dx.doi.org/10.1136/jnnp-2019-321532
,2020, 'Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study) Study protocol clinical trial (SPIRIT Compliant)', MEDICINE, 99, http://dx.doi.org/10.1097/MD.0000000000018904
,2020, 'Sonographic assessment of nerve blood flow in diabetic neuropathy', Diabetic Medicine, 37, pp. 343 - 349, http://dx.doi.org/10.1111/dme.14085
,2020, 'Erratum: A Neuroethics Framework for the Australian Brain Initiative (Neuron (2019) 101(3) (365–369), (S0896627319300054), (10.1016/j.neuron.2019.01.004))', Neuron, 105, pp. 201, http://dx.doi.org/10.1016/j.neuron.2019.12.019
,2020, 'ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization', Brain Communications, 2, http://dx.doi.org/10.1093/braincomms/fcaa064
,2020, 'Jewels in the crown: A century of achievement for the Journal of Neurology, Neurosurgery & Psychiatry', Journal of Neurology Neurosurgery and Psychiatry, 91, http://dx.doi.org/10.1136/jnnp-2019-322443
,2020, 'Massive retroperitoneal hemorrhage after external shock wave lithotripsy in a patient with a left ventricular assist device', UROLOGY CASE REPORTS, 28, http://dx.doi.org/10.1016/j.eucr.2019.101033
,2020, 'Measurement of axonal excitability: Consensus guidelines', Clinical Neurophysiology, 131, pp. 308 - 323, http://dx.doi.org/10.1016/j.clinph.2019.07.023
,2020, 'Neurophysiological features of primary lateral sclerosis', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21, pp. 11 - 17, http://dx.doi.org/10.1080/21678421.2020.1837174
,2020, 'Preface: promoting research in PLS: current knowledge and future challenges', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21, pp. 1 - 2, http://dx.doi.org/10.1080/21678421.2020.1840795
,2020, 'Quantification of Small Fiber Neuropathy in Chemotherapy-Treated Patients', Journal of Pain, 21, pp. 44 - 58, http://dx.doi.org/10.1016/j.jpain.2019.06.011
,2020, '11. Neurophysiological correlates of impaired cognition in Amyotrophic Lateral Sclerosis', Clinical Neurophysiology, 131, pp. e5 - e5, http://dx.doi.org/10.1016/j.clinph.2019.11.044
,2020, '12. EMG bursting characteristics of upper limb muscles in patients with CIDP and tremor', Clinical Neurophysiology, 131, pp. e5 - e6, http://dx.doi.org/10.1016/j.clinph.2019.11.045
,2020, '13. Transcallosal dysfunction an early marker of ALS', Clinical Neurophysiology, 131, pp. e6 - e6, http://dx.doi.org/10.1016/j.clinph.2019.11.046
,2020, '15. Paraproteinaemic neuropathy: The role for nerve biopsy', Clinical Neurophysiology, 131, pp. e7 - e7, http://dx.doi.org/10.1016/j.clinph.2019.11.048
,2020, '5. Neurophysiological characteristics in the development and recovery of peripheral neuropathy in oxaliplatin and paxlitaxel treated patients', Clinical Neurophysiology, 131, pp. e2 - e3, http://dx.doi.org/10.1016/j.clinph.2019.11.038
,2020, '6. Motor neuron disease with malignancy: a pathophysiologically distinct entity of motor neuron disease?', Clinical Neurophysiology, 131, pp. e3 - e3, http://dx.doi.org/10.1016/j.clinph.2019.11.039
,2020, '8. Electrophysiological and phenotypic profiles of taxane-induced neuropathy', Clinical Neurophysiology, 131, pp. e4 - e4, http://dx.doi.org/10.1016/j.clinph.2019.11.041
,2020, 'Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy', NEUROBIOLOGY OF AGING, 92
,2019, 'Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice', Journal of Neurology Neurosurgery and Psychiatry, 91, pp. 162 - 171, http://dx.doi.org/10.1136/jnnp-2019-321790
,2019, 'TDP-43 levels in the brain tissue of ALS cases with and without C9ORF72 or ATXN2 gene expansions', Neurology, 93, pp. e1748 - e1755, http://dx.doi.org/10.1212/WNL.0000000000008439
,2019, 'COG-01 Phenotypic variation in ALS-FTD and effect on survival', Amyotrophic Lateral Sclerosis Frontotemporal Degeneration, 20, pp. 301 - 308, http://dx.doi.org/10.1080/21678421.2019.1647000
,2019, 'Milestones', Journal of Neurology Neurosurgery and Psychiatry, 90, pp. 1189, http://dx.doi.org/10.1136/jnnp-2019-321711
,2019, 'Post-exercise hypotension and skeletal muscle oxygenation is regulated by nitrate-reducing activity of oral bacteria', FREE RADICAL BIOLOGY AND MEDICINE, 143, pp. 252 - 259, http://dx.doi.org/10.1016/j.freeradbiomed.2019.07.035
,2019, 'Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients', Clinical Neurophysiology, 130, pp. 2088 - 2095, http://dx.doi.org/10.1016/j.clinph.2019.08.005
,2019, 'Effect of phenotypic presentation on survival in ALS-FTD', JOURNAL OF THE NEUROLOGICAL SCIENCES, 405, http://dx.doi.org/10.1016/j.jns.2019.10.323
,2019, 'Neural correlates of body composition in frontotemporal dementia', JOURNAL OF THE NEUROLOGICAL SCIENCES, 405, http://dx.doi.org/10.1016/j.jns.2019.10.840
,2019, 'Amyotrophic lateral sclerosis as a multi-step process: an Australia population study', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20, pp. 532 - 537, http://dx.doi.org/10.1080/21678421.2018.1556697
,2019, 'Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20, pp. 595 - 604, http://dx.doi.org/10.1080/21678421.2019.1632899
,2019, 'Bortezomib Induced Peripheral Neuropathy: A Systematic Review of Phase III Trials', CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 19, pp. E346 - E346, http://dx.doi.org/10.1016/j.clml.2019.09.571
,2019, 'Consensus for experimental design in electromyography (CEDE) project: Electrode selection matrix', Journal of Electromyography and Kinesiology, 48, pp. 128 - 144, http://dx.doi.org/10.1016/j.jelekin.2019.07.008
,2019, 'CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation', Journal of Biological Chemistry, 294, pp. 14149 - 14162, http://dx.doi.org/10.1074/jbc.RA118.005263
,2019, 'Amyotrophic lateral sclerosis: Origins traced to impaired balance between neural excitation and inhibition in the neonatal period', Muscle and Nerve, 60, pp. 232 - 235, http://dx.doi.org/10.1002/mus.26617
,2019, 'Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis', Journal of Neurology Neurosurgery and Psychiatry, 90, pp. 1011 - 1020, http://dx.doi.org/10.1136/jnnp-2018-319581
,2019, 'Motor neuron disease with malignancy: Clinical and pathophysiological insights', Clinical Neurophysiology, 130, pp. 1557 - 1561, http://dx.doi.org/10.1016/j.clinph.2019.05.026
,